Lipocortin-1 and the control of arachidonic acid release in cell signalling
Jamie D. Croxtall(William Harvey Research Institute), Rod Flower(Queen Mary University of London), Hidekado Tokumoto(Ono Pharmaceutical (Japan)), Qam Choudhury(Queen Mary University of London)
Cited by 81
Related Papers
The development of COX2 inhibitors
|Nature Reviews Drug Discovery|2003|464
Lipocortin-1: cellular mechanisms and clinical relevance
|Trends in Pharmacological Sciences|1994|380
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
|British Journal of Pharmacology|2000|330
A novel role for phospholipase A <sub>2</sub> isoforms in the checkpoint control of acute inflammation
|The FASEB Journal|2004|173
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
|British Journal of Pharmacology|2002|146